#1 Clinical Trials Search in Europe

Autologous haematopoietic stem cell transplant – Diagnostics

Go back

Understanding when and how to undergo diagnostic testing before an autologous haematopoietic stem cell transplant is a vital first step in determining whether this treatment approach is right for you and ensuring that your body is ready for the intensive procedure ahead.

Introduction: Who Should Undergo Diagnostics and When

Before you can begin the journey toward an autologous haematopoietic stem cell transplant, your medical team needs to thoroughly understand your overall health and the specific condition affecting you. This is not a procedure that anyone can undergo without careful consideration, and diagnostics play a central role in making that decision safely and wisely.[5]

Diagnostics are recommended when your doctor believes that high-dose chemotherapy followed by stem cell transplantation might be beneficial for your condition. This often happens in cases where you have been diagnosed with certain types of blood cancers, which are cancers that affect the blood, bone marrow, or lymph system. The most common conditions include multiple myeloma (a cancer of plasma cells in the bone marrow), Hodgkin lymphoma, and non-Hodgkin lymphoma. In these situations, autologous transplant may be considered as an initial treatment, or it may come into play when other treatments have not been effective or when the disease has returned.[5][6]

The process of determining if you are a suitable candidate involves checking not just the cancer itself, but also your body’s ability to withstand intensive treatment. High-dose chemotherapy can cause significant side effects and increase your risk of serious infections. Therefore, healthcare providers need to evaluate your heart, lungs, kidneys, liver, and overall physical condition before proceeding. This comprehensive approach ensures that the potential benefits outweigh the risks.[5]

It is also important to seek diagnostics promptly if your condition is aggressive or rapidly evolving. In cases of severe, treatment-resistant disease, or when cancer comes back after initial treatment, early and thorough diagnostic work can open the door to a transplant option that might put the disease into long-term remission, meaning symptoms disappear and tests no longer detect signs of cancer.[5]

⚠️ Important
Diagnostic testing before a stem cell transplant is not just about confirming your diagnosis. It is about understanding whether your body can safely endure the treatment process and whether you have enough healthy stem cells to collect for the transplant. Without these assessments, the procedure could be unsafe or unsuccessful.

You should also consider undergoing diagnostics if your healthcare provider suggests that your body is producing enough healthy bone marrow cells that can be collected, frozen, and stored for later use. This is a key requirement for autologous transplant, as the procedure relies on your own cells to restore bone marrow function after chemotherapy.[1]

Classic Diagnostic Methods Used to Identify the Disease and Distinguish It from Other Conditions

Once your doctor suspects that you may benefit from an autologous stem cell transplant, a series of diagnostic tests will help confirm your diagnosis, understand the extent of the disease, and ensure that your organs are functioning well enough to handle the treatment.[5]

Blood Tests and Complete Blood Count

One of the first and most common diagnostic tools is a complete blood count (CBC), which measures the levels of different types of blood cells in your body. This test helps doctors see if your bone marrow is producing enough healthy red blood cells, white blood cells, and platelets. Low counts can indicate that the bone marrow is not functioning properly, which is common in conditions like multiple myeloma or lymphoma.[5]

Beyond the CBC, additional blood tests are used to check how well your liver and kidneys are working. These organs play a vital role in processing the chemotherapy drugs you will receive. If they are not functioning properly, the transplant plan may need to be adjusted or delayed.[5]

Biopsy to Study Cancerous Cells

A biopsy is a procedure in which a small sample of tissue or cells is removed from your body so it can be examined under a microscope. In the context of blood cancers, this often involves a bone marrow biopsy, where a needle is inserted into the hip bone to extract a sample of bone marrow. This test is crucial because it allows doctors to see exactly what type of cancer cells are present, how aggressive they are, and how far the disease has spread.[5]

The information gained from a biopsy helps distinguish one type of blood cancer from another, which is essential for planning the right treatment approach. For example, multiple myeloma looks different under the microscope than non-Hodgkin lymphoma, and each requires a different treatment strategy.

Imaging Tests

Imaging tests create detailed pictures of the inside of your body, allowing doctors to see the size and location of tumors or areas where cancer may have spread. Common imaging tests used before a stem cell transplant include computed tomography (CT) scans, which use X-rays to create cross-sectional images of your body. These scans are particularly useful for detecting swollen lymph nodes or tumors in the chest, abdomen, or pelvis.[5]

Other imaging methods may also be used depending on your specific condition. These tests help doctors understand the full extent of the disease and plan the most effective treatment.

Heart and Lung Function Tests

Because the chemotherapy used before a stem cell transplant can put strain on your heart and lungs, doctors will perform tests to make sure these organs are strong enough to handle the treatment. An electrocardiogram (EKG) measures the electrical activity of your heart and can detect irregular rhythms or signs of damage. An echocardiogram uses sound waves to create moving pictures of your heart, showing how well it is pumping blood.[5]

These tests are not only important for safety, but they also help your medical team monitor your heart throughout the transplant process and catch any problems early.

Central Venous Catheter Placement

Before your transplant begins, your doctor may place a central venous catheter (CVC) in one of the large veins in your upper chest. This is a flexible tube that stays in place throughout your treatment, allowing healthcare providers to draw blood, give medications, and infuse the stem cells without needing to repeatedly insert needles into your veins. While placing the catheter is a minor procedure, it is an important part of the diagnostic and preparatory process.[5]

Diagnostics for Clinical Trial Qualification

If you are considering joining a clinical trial that involves an autologous haematopoietic stem cell transplant, the diagnostic process may be even more detailed. Clinical trials are research studies that test new treatments or compare different treatment approaches, and they often have strict criteria for who can participate.[6]

Standard Criteria for Enrollment

Clinical trials typically require participants to meet specific health standards to ensure the safety of the study and the reliability of the results. This means you will undergo many of the same diagnostic tests described earlier, including blood tests, biopsies, imaging scans, and heart and lung function tests. However, the trial may have additional requirements or thresholds that your results must meet.[6]

For example, a trial might only accept patients whose cancer has reached a certain stage, or who have not responded to a specific number of previous treatments. These criteria help researchers gather consistent data and ensure that the new treatment is being tested on the right group of people.

Confirming Stem Cell Availability

For an autologous transplant trial, it is essential that you have enough healthy stem cells to collect. Before you can be enrolled, your medical team will often perform tests to measure the number of stem cells circulating in your blood after you receive growth factor drugs. These are hormone-like medications that stimulate your bone marrow to produce more blood cells and move them into your bloodstream, a process called mobilization.[5]

If the number of stem cells is too low, you may not be able to join the trial, or your doctors may need to try a different approach to collect enough cells.

Additional Monitoring and Testing

Clinical trials often involve more frequent monitoring and additional tests compared to standard treatment. This might include extra blood draws, imaging scans, or biopsies at specific points during and after the transplant. These tests help researchers track how well the treatment is working and identify any side effects or complications early.[6]

While this can seem like a lot of extra work, it also means you will be closely watched by a dedicated medical team, which can provide an additional layer of safety and care.

⚠️ Important
Participating in a clinical trial may give you access to new treatments that are not yet widely available. However, it also requires a commitment to more frequent testing and follow-up visits. It is important to discuss the benefits and potential burdens with your healthcare team before deciding to enroll.

Informed Consent and Screening

Before joining a clinical trial, you will go through an informed consent process, where the research team explains the purpose of the study, the procedures involved, the potential risks and benefits, and your rights as a participant. As part of this process, you will undergo screening tests to confirm that you meet all the eligibility criteria. Only after these steps are completed can you officially enroll in the trial.[6]

The screening process is thorough because it protects both you and the integrity of the research. It ensures that the trial is studying a well-defined group of patients, which makes the results more reliable and meaningful for future patients.

Prognosis and Survival Rate

Prognosis

The outlook for patients who undergo an autologous haematopoietic stem cell transplant depends on many factors, including the type and stage of the disease being treated, the patient’s overall health before the transplant, and how well the body responds to the high-dose chemotherapy and stem cell infusion. This procedure is not intended to cure all cancers, but research has shown that it can lead to long-term remission for certain blood cancers, particularly multiple myeloma. Long-term remission means that symptoms disappear and tests no longer detect signs of the disease.[5]

For patients with treatment-resistant cancer or cancer that has returned after initial treatment, an autologous stem cell transplant may offer a chance to control the disease when other options have been exhausted. However, the transplant process is intensive and carries risks, including infections, organ damage, and complications from chemotherapy. The chances of a positive outcome are generally better for patients who are younger, have fewer other health problems, and whose cancer has not spread extensively.[5]

Recovery from a stem cell transplant can take a long time, often up to a year or more, before patients truly feel they are back to normal. During this period, the immune system gradually rebuilds, and the body heals from the effects of chemotherapy. Close monitoring and follow-up care are essential to catch any complications early and support the patient’s recovery.[5]

Survival Rate

Unfortunately, the sources provided do not contain specific survival rate statistics for patients undergoing autologous haematopoietic stem cell transplants. Survival outcomes can vary widely depending on the type of blood cancer, the stage of the disease, and individual patient factors. It is important to discuss your personal prognosis and expected outcomes with your healthcare team, as they can provide information tailored to your specific situation.

Ongoing Clinical Trials on Autologous haematopoietic stem cell transplant

  • Study Comparing Two Drug Combinations for Blood Cancer Patients: Rabbit Anti-Human Thymocyte Immunoglobulin vs. Anhydrous Cyclophosphamide

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium

  • Study on Gene Therapy for Patients with RAG1-Deficient Severe Combined Immunodeficiency Using RAG1-LV-CD34+ Cells

    Recruiting

    1 1
    Investigated diseases:
    Italy The Netherlands Poland Spain

  • Study Comparing Fosfomycin and Ciprofloxacin for Preventing Fever in Patients with Acute Leukemia After Chemotherapy or Stem Cell Transplant

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

References

https://www.mayoclinic.org/tests-procedures/autologous-stem-cell-transplant/pyc-20384859

https://pmc.ncbi.nlm.nih.gov/articles/PMC6334059/

https://www.mdanderson.org/cancerwise/what-are-autologous-stem-cell-transplants.h00-159540534.html

https://www.cancer.gov/publications/dictionaries/cancer-terms/def/autologous-stem-cell-transplant

https://my.clevelandclinic.org/health/procedures/autologous-stem-cell-transplant

https://emedicine.medscape.com/article/208954-overview

https://www.mskcc.org/cancer-care/patient-education/autologous-stem-cell-transplant-guide-patients-caregivers

https://www.mayoclinic.org/tests-procedures/autologous-stem-cell-transplant/pyc-20384859

https://pmc.ncbi.nlm.nih.gov/articles/PMC6334059/

https://www.mdanderson.org/cancerwise/what-are-autologous-stem-cell-transplants.h00-159540534.html

https://www.nature.com/articles/s41582-024-01050-x

https://my.clevelandclinic.org/health/procedures/autologous-stem-cell-transplant

https://emedicine.medscape.com/article/208954-overview

https://www.mskcc.org/cancer-care/patient-education/autologous-stem-cell-transplant-guide-patients-caregivers

https://www.fredhutch.org/en/news/spotlight/2024/06/crd-split-transplantcelltherapy.html

https://sctpatiented.dana-farber.org/precautions-inside-your-home1.html

https://www.mdanderson.org/cancerwise/need-a-stem-cell-transplant–4-tips-to-make-your-life-easier.h00-159702279.html

https://www.anthonynolan.org/patients-and-families/recovering-a-stem-cell-transplant

https://www.mdanderson.org/cancerwise/autologous-stem-cell-transplant-survivor-what-to-expect.h00-158989023.html

https://www.cancerresearchuk.org/about-cancer/treatment/bone-marrow-stem-cell-transplants/after

https://www.anthonynolan.org/patients-and-families/recovering-a-stem-cell-transplant/diet-after-a-stem-cell-transplant

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

More information about
Autologous haematopoietic stem cell transplant:

FAQ

What tests do I need before an autologous stem cell transplant?

Before an autologous stem cell transplant, you will need a variety of tests to check your overall health and the status of your disease. These typically include blood tests (such as a complete blood count and liver and kidney function tests), a biopsy to study cancerous cells, imaging tests like CT scans, and heart and lung function tests such as an electrocardiogram and echocardiogram. These tests help your doctor determine if your body is strong enough for the intensive treatment and whether you have enough healthy stem cells to collect.[5]

How do doctors know if I have enough stem cells for a transplant?

Doctors assess whether you have enough stem cells by first giving you growth factor drugs, which are medications that stimulate your bone marrow to produce more blood cells and release them into your bloodstream. After this mobilization process, your medical team will measure the number of stem cells in your blood through testing. If the count is high enough, they will proceed with collecting the cells through a process called apheresis. If the number is too low, they may try different approaches or medications to increase the stem cell yield.[5]

Why do I need heart and lung tests before a stem cell transplant?

Heart and lung tests are essential because the high-dose chemotherapy you receive before the stem cell transplant can place significant stress on these organs. Tests like an electrocardiogram (EKG) and echocardiogram check how well your heart is functioning and whether it can handle the treatment. These assessments help your medical team plan the safest and most effective treatment and monitor your organs throughout the transplant process to catch any problems early.[5]

What is a biopsy and why is it necessary?

A biopsy is a procedure where a small sample of tissue or cells is removed from your body and examined under a microscope. For blood cancers, this often involves a bone marrow biopsy, where a needle is inserted into the hip bone to extract bone marrow. The biopsy is necessary because it allows doctors to see exactly what type of cancer cells are present, how aggressive they are, and how far the disease has spread. This information is crucial for confirming your diagnosis and planning the most effective treatment.[5]

Can I join a clinical trial if I need a stem cell transplant?

Yes, you may be able to join a clinical trial if you meet the specific eligibility criteria set by the research study. Clinical trials often require participants to undergo additional diagnostic tests and monitoring to ensure they fit the study’s requirements. These trials may give you access to new treatments that are not yet widely available, but they also require a commitment to more frequent testing and follow-up visits. It is important to discuss the potential benefits and burdens with your healthcare team before deciding to enroll.[6]

🎯 Key Takeaways

  • • Diagnostics before an autologous stem cell transplant are essential to confirm your diagnosis, assess your overall health, and determine if your body can safely handle intensive treatment.
  • • Common diagnostic tests include blood tests, biopsies, imaging scans like CT scans, and heart and lung function tests such as electrocardiograms and echocardiograms.
  • • A bone marrow biopsy allows doctors to examine cancer cells under a microscope, helping them understand the type and aggressiveness of the disease.
  • • Growth factor drugs are used to stimulate your bone marrow to produce more stem cells, which are then collected through a process called apheresis.
  • • Clinical trials for stem cell transplants often have strict eligibility criteria and require additional testing and monitoring to ensure participant safety and study reliability.
  • • An autologous transplant uses your own stem cells, which eliminates the risk of compatibility issues that can occur with donor cells.
  • • Recovery from a stem cell transplant can take up to a year or longer, and close follow-up care is essential to monitor your progress and catch complications early.
  • • Research shows that autologous stem cell transplants can lead to long-term remission in certain blood cancers, particularly multiple myeloma, meaning symptoms disappear and tests no longer detect the disease.

Connected medications: